Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA*

Journal of Vascular Surgery

Volumn 19, Issue 1, 1994, Pages 125-134

  Choi, Eric T ^a   Engel, Leslie ^a   Callow, Allan D ^a   Sun, Shaping ^a   Trachtenberg, Jeffery ^a   Santoro, Sam ^a   Ryan, Una S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INTEGRIN; MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LM 609; PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; CAROTID ARTERY; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0028137599     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(94)70127-X     Document Type: Article

References (31)

1. Restenosis after successful angioplasty: pathophysiology and prevention
2. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia
3. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients
4. Incidence of restenosis after successful coronary angioplasty a time related phenomena: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months
5. Current status of vascular grafts
6. Recognition and management of impending vein-graft failure importance for long-term patency
7. Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia
8. Angioscopy of arm vein infrainguinal bypass grafts
9. Distal anastomotic intimal hyperplasia: histopathologic character and biogenesis
10. Kinetics of cellular proliferation after arterial injury: III—endothelial and smooth muscle growth in chronically denuded vessels
11. Arterial response to mechanical injury: balloon catheter de-endothelialization
12. Significance of quiescent smooth muscle migration in the injured rat carotid artery
13. Integrins: a family of cell surface receptors
14. Upregulated biosynthesis and expression of endothelial cell vitronectin receptor enhances cancer cell adhesion
15. 5β1 in promoting cellular attachment and spreading on fibronectin
16. vβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface
17. vβ3 integrin
18. vβ3 integrin in human melanoma cell invasion
19. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction
20. Vasoconstriction: a new biological activity of platelet-derived growth factor
21. Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: production of a platelet-derived growth factor—like mitogen and expression of a gene for a platelet-derived growth factor—a preliminary study
22. The inhibitory effect of FK506 on intimal hyperplasia
23. The synergistic effect of hypercholesterolemia and mechanical injury on intimal hyperplasia
24. Vascular permeability factor (VPF) speeds endothelial repaving following arterial injury
25. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery
26. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition
27. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
28. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor β1 and by platelet-derived growth factor-BB
29. 2β1 integrin receptor
30. In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent